Showing posts with label Drugs for Neglected Diseases Initiative (DNDi) as a "Commons" for public health. Show all posts
Showing posts with label Drugs for Neglected Diseases Initiative (DNDi) as a "Commons" for public health. Show all posts

Tuesday, February 26, 2019

New Research Study Describes DNDi As A “Commons” For Public Health; Intellectual Property Watch, February 25, 2019

David Branigan, Intellectual Property Watch; New Research Study Describes DNDi As A “Commons” For Public Health

"Since 2003, Drugs for Neglected Diseases Initiative (DNDi) has worked to meet the public health needs of neglected populations by filling gaps in drug development left by the for-profit pharmaceutical industry. A new research study by the French Development Agency analysed DNDi’s unique product development partnership (PDP) model, and found that it “illustrate[s] what can be presented as a ‘commons’ within the area of public health."

The research study, “DNDi, a Distinctive Illustration of Commons in the Area of Public Health,” was published earlier this month by the Agence Française de Développement (AFD), the French public development bank that “works in many sectors — energy, healthcare, biodiversity, water, digital technology, professional training, among others — to assist with transitions towards a safer, more equitable, and more sustainable world: a world in common,” according to its website."